kras mutation and glutathion glynac Oncogenic Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell The Metabolic Landscape of RAS-Driven
The Metabolic Landscape of RAS Driven Cancers from biology to therapy PMC Treatment of KRAS Mutated Pancreatic Cancer: New Hope for the Patients? Pancreatic Cancer: Advances and Challenges PMC KRAS Targeted Therapy Doubles as Component of Immunotherapy NCI KRAS: feeding pancreatic cancer proliferation: Trends in Biochemical Sciences KRAS G12 mutant alleles differentially control glutamine metabolism via FOXO1 bioRxiv
Pay in 4 interest-free payments of $6.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13





